| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |